Hindi Tamil Telugu
    More
    In the news
    Narendra Modi
    Amit Shah
    Box Office Collection
    Bharatiya Janata Party (BJP)
    OTT releases
    Hindi Tamil Telugu
    User Placeholder

    Hi,

    Logout

    India
    Business
    World
    Politics
    Sports
    Technology
    Entertainment
    Auto
    Lifestyle
    Inspirational
    Career
    Bengaluru
    Delhi
    Mumbai

    Download Android App

    Follow us on
    • Facebook
    • Twitter
    • Linkedin
    Home / News / Technology News / Delayed second Pfizer shot boosts immunity by over three times
    Next Article
    Delayed second Pfizer shot boosts immunity by over three times
    Pfizer COVID-19 vaccine doses are normally administered at a three-week interval

    Delayed second Pfizer shot boosts immunity by over three times

    By Nikita Gupta
    (PTI desk)
    May 21, 2021
    06:34 pm

    What's the story

    Delay in giving a second dose of the Pfizer COVID-19 vaccine by 12 weeks increases antibody response in older people by three-and-a-half times compared to those who receive it at a three-week interval, according to a study conducted in the UK.

    The study conducted on 175 people aged over 80 is the first direct comparison of the immune response to the different time intervals.

    Research

    Previously infected participants were not part of this analysis

    Of the cohort, 99 participants had the second vaccine at three weeks, while 73 had the second dose at 12 weeks.

    Ten in the three-week interval group and five in the 12-week interval group who were previously infected were excluded from the analysis as a previous infection has been shown to have a major impact on the immune response to vaccination.

    You're
    25%
    through

    Study

    Increased interval enhances and extends antibody immunity

    The team said that extending the administration of the second dose to 12-weeks potentially enhances and extends antibody immunity, which is important in virus neutralization and prevention of infection.

    "SARS-CoV-2 vaccines have been remarkably effective in providing large-scale protection, but questions remain regarding their optimal delivery for provision of effective and sustained immunity," said study's first author Helen Parry from the University of Birmingham.

    You're
    50%
    through

    Vaccine doses

    Enhanced antibody responses might help to sustain immunity

    Understanding how to optimize COVID-19 vaccine schedules and maximize immune responses within the older age group is important, Parry said.

    "The enhanced antibody responses seen after an extended interval may help to sustain immunity against COVID-19 over the longer term and further improve the clinical efficacy of the vaccine," said the corresponding author of the study, Paul Moss, from the University of Birmingham.

    You're
    75%
    through

    COVID-19 vaccination

    Several countries have expanded to a 12-week interval

    The finding comes days after the UK government reduced the gap between the two doses of COVID-19 vaccines to eight weeks, while India extended the interval between two doses of the Covishield to 12-16 weeks, up from the previous maximum of eight weeks.

    Several countries expanded to a 12-week interval to allow a higher percentage of the population to receive one vaccine dose.

    Done!
    Facebook
    Whatsapp
    Twitter
    Linkedin
    Related News
    Latest
    Pfizer
    COVID-19
    COVID-19 Vaccine

    Latest

    IPL 2025: Which teams will seal top two spots?   Chennai Super Kings (CSK)
    'Hera Pheri': Rawal has 1-2 days to tackle ₹25cr notice  Akshay Kumar
    Sai Sudharsan focused on IPL 2025 playoffs amid England tour Sai Sudharsan
    Sleek, smart, screenless—The AI device Altman, Jony Ive are building China

    Pfizer

    Serum seeks emergency use approval for Oxford's coronavirus vaccine Oxford
    COVID-19 vaccine: 90-year-old woman receives first Pfizer shot in UK Oxford University
    Pfizer vaccine: UK issues allergy warning after two adverse reactions Europe
    US clears Pfizer coronavirus vaccine, first shot in 24 hours Vaccine

    COVID-19

    Vitalik Buterin's $1 billion COVID-19 donation: Fact or farce? Cryptocurrency
    Centre issues new guidelines to combat COVID-19 in rural areas Union Health Ministry
    Navneet Kalra arrested for black marketing of oxygen concentrators India
    Television journalist Anjan Bandyopadhyay dies after battle with COVID-19 West Bengal

    COVID-19 Vaccine

    Google's US office facilities will serve as COVID-19 vaccination clinics Google
    World faces 'existential threats,' fragilities: UN chief Antonio Guterres
    COVID-19 pandemic may take four to five years to end Singapore
    US to purchase additional 200 million coronavirus vaccine doses Pfizer
    Indian Premier League (IPL) Celebrity Hollywood Bollywood UEFA Champions League Tennis Football Smartphones Cryptocurrency Upcoming Movies Premier League Cricket News Latest automobiles Latest Cars Upcoming Cars Latest Bikes Upcoming Tablets
    About Us Privacy Policy Terms & Conditions Contact Us Ethical Conduct Grievance Redressal News News Archive Topics Archive Download DevBytes Find Cricket Statistics
    Follow us on
    Facebook Twitter Linkedin
    All rights reserved © NewsBytes 2025